Sep 12, 2017   SOURCE: PR NewsWire

The 5th International mRNA Health Conference to Showcase Advances in mRNA Cancer Therapy, Antibody Development and Vaccines

TÜBINGEN, Germany and BERLIN, Sept. 12, 2017 /PRNewswire/ -- The 5th International mRNA Health Conference has unveiled the preliminary schedule for its two-day conference taking place on November 1-2 in Berlin, Germany. The conference will include talks and panel discussions focused on the evolution of groundbreaking mRNA research to next-generation pharmaceutical products targeting treatment opportunities in cancer, vaccination against infectious diseases, as well as antibody development and protein replacement therapy. The event will be highlighted by a keynote address from extreme mountaineer Reinhold Messner.

Early-bird registration for the 5th International mRNA Health Conference ends on September 15, 2017. To register and benefit from the discounted entry fee, please visit http://mrna-conference.com/register/.

The 5th International mRNA Health Conference 

    Date:         November 1-2, 2017


    Place:        Berlin, Germany


    Location:      Sofitel Berlin Kurfürstendamm, Augsburger Strasse 41,
                   10789 Berlin, Germany


    Website:      www.mrna-conference.com


    Program:       The Conference, organized by BioNTech, CureVac and
                   Moderna, will provide a comprehensive program around the
                   medical use of Messenger RNA. Hundreds of world renowned
                   innovators, scientists, academia and pharmaceutical
                   delegates are expected to attend the conference as mRNA
                   therapeutic technology evolves from scientific concept
                   to medical application. Approximately 25 speakers will
                   present on preclinical and clinical development in the
                   fields of oncology, infectious diseases and molecular
                   therapies as well as mRNA delivery, design and product
                   development. Additionally, a poster session will provide
                   research groups and company representatives the
                   opportunity to showcase their data to attendees.


    Registration:  Register by September 15th and benefit from early bird
                   prices
                  http://mrna-conference.com/register/


    Contact:      organization@mrna-conference.com

Media Contacts

Verena Lauterbach, Senior Manager Communications
CureVac AG, Tübingen, Germany
T: +49 (0) 7071 9883 1756
verena.lauterbach@curevac.com

Jason Rando, EVP & COO
Tiberend Strategic Advisors, New York
+1 212 375 2665
jrando@tiberend.com

View original content with multimedia:http://www.prnewswire.com/news-releases/the-5th-international-mrna-health-conference-to-showcase-advances-in-mrna-cancer-therapy-antibody-development-and-vaccines-300517807.html

SOURCE CureVac